達文西機器手臂輔助攝護腺根除術-台北榮總經驗
陳嘉宏1、林子平1,2、鍾孝仁1,2、林登龍1,2、陳光國1,2
台北榮民總醫院 泌尿部1；國立陽明大學醫學院 泌尿學科 書田泌尿科學研究中心2
Robot-assisted radical prostatectomy-
A single institute experience
Chia-Hung Chen1, Tzu-Ping Lin 1,2, Hsiao-Jen Chung1,2, Alex T.L. Lin1,2, Kuang-Kuo Chen1,2
Department of Urology, Taipei Veterans General Hospital1
Department of Urology, School of Medicine and Shu-Tien Urological Institute, National Yang-Ming University, Taipei, Taiwan2
Purpose: The aim of this study was to describe surgical, oncological and functional outcomes for patients undergoing robot-assisted radical prostatectomy (RARP)
Materials and Methods:
From 2009 to November 2015, total 362 patients with prostate cancer were treated with robot-assisted radical prostatectomy at Taipei Veterans General Hospital. We collected patient and tumor characteristics. Perioperative outcomes, oncologic outcome, and functional outcomes were recorded.
Results: Total 362 patients were included in our study. The mean age was 63.35 ± 5.23 and the mean body mass index was 25.0 ± 2.36. Mean pre-operation PSA was 11.7±6.37. Mean estimated blood loss was 190.7±191.92ml. Mean days of Foley removal was 5.6±2.63. Mean days of post-op hospital days was 6.65±1.85. Complications occurred in 75 cases (20%), with 58 gradeI, 12 gradeII, 2 gradeIIIa, and 3 gradeIIIb by Clavien-Dindo classificaiton. Positive surgical margin was 28%. Continence rate was 85.56% % after 1 year follow-up. Potency rate was 60.81% after 1 year follow-up. Biochemical recurrence rate was 13.56%. Mean follow-up period was 28.24±17.89 months. Factor will influence biochemical recurrence including value of PSA, gleason score, risk group, and margin status.
Conclusions:
According to our study and literature review. RARP is a safe procedure with regard to perioperative results. Functional outcome was better than previous study in our hospital.